|
|
|
|
GMMMG Consultations |
|
|
On this page you will find proposed changes that are currently going through the GMMMG approval process. This will include consultations on proposed RAG status, updated Formulary Chapters, Pathways or other GMMMG Guidance. You will be able to comment on current proposals via the links in the table below. Due to the COVID-19 outbreak all active GMMMG consultations were temporarily suspended in April. The active consultations have now been re-opened; please see below for the new end dates. Every effort has been made to allow sufficient time for appropriate clinical input to these documents, but if you foresee any problems or have any questions please email nuth.enquires.gmmmg@nhs.net |
|
|
Title |
Information |
Feedback |
End date |
|
|
105 |
GMMMG Clinical Reference Group - Shared Care Protocol for hydroxychloroquine |
On behalf of the GMMMG Clinical Reference Group, a shared care protocol for hydroxychloroquine in adults in the updated shared care template is in development. We now seek comments on this draft. This consultation period is open until 5pm Wednesday 2nd June 2021. |
5pm Wednesday |
|
|
104 |
On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed in the April 21 CRG meeting. This consultation period is open until 5pm Wednesday 2nd June 2021. |
5pm Wednesday |
||
|
103 |
On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed in the Dec 20 and Jan 21 CRG meetings and temporary decisions made by GM Chairs during the pause of non-essential GM activity. This consultation period is open until 5pm Thursday 13th May 2021. |
5pm Thursday |
||
<< Back
